Dr. Chiang joined the company in May of 2005 and is responsible for the company’s technology strategy and direction. Prior to joining Intermolecular, he founded Angstron Systems Inc., a venture-backed ALD start-up that was acquired by Novellus Systems Inc. Following the acquisition, Dr. Chiang served as Novellus’ manager of productization of the iALD technology for advanced copper-barrier and seed applications. Earlier in his career, he worked at Applied Materials Inc., where he developed several generations of advanced-ionized and self-ionized physical vapor deposition (PVD) technologies. He received a B.S. degree in materials science and engineering from Cornell University and a Ph.D. in materials science and engineering from MIT. Dr. Chiang holds 52 patents in the field of advanced semiconductor processing technologies. |